Stock Events

Stock Events

Spero Therapeutics (SPRO) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.38

0.07

0.51

0.96

Details

Expected EPS

-0.265

Actual EPS

-0.32

Surprise EPS

-0.05

Surprise Percent

+20.75%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.32 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.